Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precigen Bioinformatics Germany was a Germany-based bioinformatics and scientific services subsidiary of Precigen focused on the development and commercialization of scientific products and the provision of scientific services, including project management and scientific consulting. The entity appears to have represented the former Genomatix business within the Precigen corporate structure rather than a therapeutic drug-development company. It was ultimately a subsidiary of Precigen and was not itself a clinical-stage biotech sponsor with a disclosed therapeutic pipeline. Public corporate registry records indicate the company entered liquidation in May 2022 and was deleted from the registry in January 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precigen Bioinformatics.